Discussion: However, even the investigated DARPin domains aVEGF and aHER2 that possess framework mutations, which are key for their low picomolar binding affinities, still profit from the
Asp17Leu mutation.
Discussion: Importantly, the MD simulations show t
Discussion: Quantitative dimension and additive nature of the
Asp17Leu improvement.